Hypertrophy of the medial globus pallidus in 6-hydroxydopamine-lesioned rats treated with levodopa

被引:0
|
作者
Tomiyama, M [1 ]
Mori, F [1 ]
Kimura, T [1 ]
Wakabayashi, K [1 ]
Matsunaga, M [1 ]
机构
[1] Hirosaki Univ, Dept Neurol Sci, Inst Brain Sci, Sch Med, Hirosaki, Aomori 0368562, Japan
来源
ADVANCES IN BRAIN RESEARCH: CEREBROVASCULAR DISORDERS AND NEURODEGENERATION | 2003年 / 1251卷
关键词
dyskinesia; L-DOPA; 6-OHDA; sensitization; Parkinson's disease;
D O I
10.1016/S0531-5131(03)00116-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The motor effects of levodopa, evidenced by rotation behavior, became enhanced upon intermittent administration in rats with unilateral lesions of the nigrostriatal dopamine pathway by 6-hydroxydopamine (6-OHDA). However, the mechanisms of this behavioral sensitization, which is regarded to be analogous to levodopa-induced dyskinesias (LIDs) in patients with Parkinson's disease (PD), remain unknown. The fact that pallidotomy dramatically improves LIDs indicates that the medial globus pallidus (MGP) plays an important role in the development of LIDs. We found hypertrophy of the MGP in 6-OHDA-lesioned rats treated with levodopa twice daily for 2 weeks. The rats showed marked behavioral sensitization to levodopa. Furthermore, coadministration of 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) with levodopa attenuated this hypertrophy together with prevention of the sensitization. These results suggest that this hypertrophy is an essential pathological change in the rodent model of LIDs. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 50 条
  • [21] Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA
    Tomiyama, M
    Kimura, T
    Maeda, T
    Tanaka, H
    Kannari, K
    Baba, M
    SYNAPSE, 2004, 52 (03) : 218 - 222
  • [22] SITE-SPECIFIC ACTION OF L-3,4-DIHYDROXYPHENYLALANINE IN THE STRIATUM BUT NOT GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA EVOKES DYSKINETIC MOVEMENTS IN CHRONIC L-3,4-DIHYDROXYPHENYLALANINE-TREATED 6-HYDROXYDOPAMINE-LESIONED RATS
    Buck, K.
    Voehringer, P.
    Ferger, B.
    NEUROSCIENCE, 2010, 166 (02) : 355 - 358
  • [23] Zolpidem ameliorates motor impairments in the unilaterally 6-hydroxydopamine-lesioned rat
    Assini, Robert
    Abercrombie, Elizabeth D.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2018, 48 (03) : 1896 - 1905
  • [24] In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats
    Sarre, S
    Yuan, H
    Jonkers, N
    Van Hemelrijck, A
    Ebinger, G
    Michotte, Y
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (01) : 29 - 39
  • [25] Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats
    Anichtchik, OV
    Huotari, M
    Peitsaro, N
    Haycock, JW
    Männistö, PT
    Panula, P
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (11) : 3823 - 3832
  • [26] Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats
    Garcia-Arencibia, Moises
    Ferraro, Luca
    Tanganelli, Servio
    Fernandez-Ruiz, Javier
    NEUROSCIENCE LETTERS, 2008, 438 (01) : 10 - 13
  • [27] Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats
    Arai, A
    Kannari, K
    Shen, H
    Maeda, T
    Suda, T
    Matsunaga, M
    BRAIN RESEARCH, 2003, 972 (1-2) : 229 - 234
  • [28] Ceftriaxone Ameliorates Motor Deficits and Protects Dopaminergic Neurons in 6-Hydroxydopamine-Lesioned Rats
    Leung, T. C. H.
    Lui, C. N. P.
    Chen, L. W.
    Yung, W. H.
    Chan, Y. S.
    Yung, K. K. L.
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (01): : 22 - 30
  • [29] Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats
    Liu, Chun-Qing
    Chen, Zhong
    Liu, Fuain
    Hu, Dan-Na
    Luo, Jian-Hong
    NEUROPHARMACOLOGY, 2007, 53 (07) : 832 - 841
  • [30] Subtle Cardiovascular Dysfunction in the Unilateral 6-Hydroxydopamine-Lesioned Rat
    Slack, K.
    Billing, R.
    Matthews, S.
    Allbutt, H. N.
    Einstein, R.
    Henderson, J. M.
    PARKINSONS DISEASE, 2010, 2010